EVENITY® (Amgen Inc)
(https://evenity.com) 📸 Data Snapshot: May 30, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Trust theatre is present primarily through the use of patient testimonials that lack direct verification. The site shows a review_count of 2-3 across pages with a proof_links_count of 0, meaning ‘astounding’ outcomes are presented without links to the specific clinical trial data or patient case studies in the immediate text. Claims like ‘PROVEN TO SIGNIFICANTLY REDUCE’ and ‘Only FDA-approved treatment that does both’ are bold performance assertions that, while likely true in a regulatory sense, lack direct outbound citations to peer-reviewed journals or ClinicalTrials.gov within the crawled content.
Proof density is anchored by technical specificity rather than external validation links. The site cites the 12-month treatment duration and the dual mechanism of action as evidence of uniqueness, but the ratio of verifiable evidence (raw data) to vague assertions (‘grew a lot of bone’) is low in the consumer-facing text. There are approximately 2-3 specific technical markers (DXA results mentioned, dual mechanism) against 7+ instances of broad marketing repetition.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /about-evenity/how-evenity-works/ | 2 | 0 |
| /contact-us/ | 2 | 0 |
| /results-and-safety/clinical-trial-results/ | 3 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
[
{
"@context": "https://schema.org",
"@type": "WebSite",
"url": "https://www.evenity.com/",
"name": "EVENITY®",
"publisher": {
"@type": "Organization",
"name": "Amgen Inc"
}
},
{
"@context": "https://schema.org",
"@type": "Drug",
"isProprietary": true,
"name": "EVENITY® (romosozumab_aqqg)",
"activeIngredient": "romosozumab_aqqg",
"administrationRoute": "injection",
"dosageForm": "injection",
"prescriptionStatus": "PrescriptionOnly",
"drugClass": {
"@type": "DrugClass",
"name": "sclerostin inhibitor"
},
"relatedDrug": {
"@type": "Drug",
"name": "Prolia"
},
"manufacturer": {
"@type": "Organization",
"name": "Amgen Inc"
}
}
]
/about-evenity/how-evenity-works/
[
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"medicalAudience": "Patient",
"specialty": "Rheumatology",
"url": "https://www.evenity.com/about-evenity",
"headline": "EVENITY® (romosozumab_aqqg) Patient Home Page",
"description": "Learn more about EVENITY®, a treatment for women with postmenopausal osteoporosis. See Full Prescribing & Safety info.",
"primaryImageOfPage": "https://www.evenity.com/-/media/Themes/Amgen/Evenity-com/Evenity-com/images/Redesign/Icons/how-evenity-works.png",
"mainContentOfPage": {
"@type": "WebPageElement",
"name": "EVENITY is a one-of-a-kind osteoporosis treatment—the first and only one that works both ways by building new bone and helping to slow bone loss."
},
"about": [
{
"@type": "MedicalProcedure",
"name": "EVENITY® (romosozumab_aqqg)",
"procedureType": "Subcutaneous",
"howPerformed": "Injection"
}
]
},
{
"@context": "https://schema.org",
"@type": "Drug",
"isProprietary": true,
"name": "EVENITY® (romosozumab_aqqg)",
"activeIngredient": "romosozumab_aqqg",
"administrationRoute": "subcutaneous",
"dosageForm": "injection",
"drugClass": "sclerostin inhibitor",
"manufacturer": {
"@type": "Organization",
"name": "Amgen Inc"
}
},
{
"@context": "https://schema.org",
"@type": "VideoObject",
"name": "Watch How Evenity Works",
"description": "How Evenity works by increasing the activity of bone-building cells and slowing down bone loss by decreasing your body's bone-removing activity",
"thumbnailUrl": "https://house-fastly-signed-eu-west-1-prod.brightcovecdn.com/image/v1/static/6415657469001/32875482-8e5b-4d9d-bd53-771f34bb934a/7d1f6a49-8d04-45c4-82a9-b241a1b3bfc8/1280x720/match/image.jpg",
"uploadDate": "2025-01-01T08:00:00+08:00",
"duration": "PT5M35S"
}
]
/contact-us/
{
"@context": "https://schema.org",
"@type": "ContactPage",
"mainEntity": {
"@type": "ContactPoint",
"telephone": "+1-888-231-5663",
"contactType": "call center representative",
"areaServed": "US",
"productSupported": "Evenity",
"availableLanguage": "en"
}
}
/results-and-safety/clinical-trial-results/
[
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"medicalAudience": "Patient",
"specialty": "Rheumatology",
"url": "https://www.evenity.com/results-and-safety/clinical-trial-results",
"headline": "EVENITY® is proven to significantly reduce spine fracture risk",
"description": "See EVENITY® clinical trial information and learn how it can help women with postmenopausal osteoporosis at a high risk for fracture. See Full Prescribing & Safety Info.",
"primaryImageOfPage": "https://www.evenity.com/results-and-safety/-/media/Themes/Amgen/Evenity-com/Evenity-com/images/Redesign/Desktop/proven-results/BMD.png",
"mainContentOfPage": {
"@type": "WebPageElement",
"name": "EVENITY is proven to significantly increase bone MINERAL density in the lumbar spine, total hip, and femoral neck"
}
},
{
"@context": "https://schema.org",
"@type": "MedicalTrial",
"name": "EVENITY Clinical Trials",
"description": "EVENITY is proven to significantly increase bone MINERAL density in the lumbar spine, total hip, and femoral neck",
"studySubject": {
"@type": "MedicalEntity",
"name": "women with postmenopausal osteoporosis"
}
}
]
This page presents a snapshot of public data from EVENITY® (Amgen Inc), captured on May 30, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to EVENITY® (Amgen Inc): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://evenity.com to view the most current version of its content and see directly what this company is about and what it offers.